Hemoglobin A1c (HbA1c) Testing Market accounted for over US$ 1.2 billion in 2019. It is anticipated to grow at a CAGR of 8.7% from 2020 to 2030.
The continual growth of the HbA1c market can be attributed to several factors including a rising number of people with diabetes and rising geriatric populations. Moreover, the launch of new FDA-approved HbA1c testing kits and assays will further contribute to the substantial growth of the global HbA1c market between 2020 and 2030. To obtain better insights related to the market scenario, prominent players are focusing on collaborative initiatives with other players in the market. For instance, in 2020, Avricore Health Inc. announced the signing of a Letter of Intent (LOI) with a publicly-traded healthcare technology company and drug maker. This was aimed at integrating a propriety point-of-care blood chemistry analyzer into the company’s HealthTab real-time data reporting system to add hba1c blood glucose testing to its real-time data reporting system. By interfacing this new analyzer with the HealthTab + RASTR, HealthTab will offer HbA1c blood glucose testing, in turn, expanding its capabilities for diabetes risk detection in patients. Additionally, it will facilitate healthcare teams in managing treatment programs for diabetes.
Major Key Players of the Hemoglobin A1c (HbA1c) Testing Market are:
Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd., ARKRAY, Inc., PTS Diagnostics, Tosoh Corporation, Trinity Biotech, SEBIA, and Nova Biomedical, among others.
Download PDF to Know the Impact of COVID-19 on “Hemoglobin A1c (HbA1c) Testing Market” at: https://www.marketindustryreports.com/pdf/406
Diabetes is a major health problem of the 21st century, which causes severe long-term damages to the cardiovascular & nervous systems as well as the eyes and kidneys. Nowadays, the prevalence of diabetes is rising globally in developed as well as developing countries. Diabetes is being commonly observed among geriatric populations. For instance, according to the International Diabetes Federation, in 2019, approximately 463 million adults (20-79 years) were having diabetes and the number is expected to rise to 700 million by 2045. One in five people in the age group, 65 years & above has diabetes. Therefore, its rising prevalence has led to an increasing need for the diagnosis & monitoring of the disease. Such a rising prevalence of diabetes will, in turn, drive the market growth.
The Hemoglobin A1c (HbA1c) Testing Market is segmented on the basis of Product Types, Technology, Application and region.
Major Product Types of Hemoglobin A1c (HbA1c) Testing Market covered are:
- Instruments
- Consumables
Major Technology of Hemoglobin A1c (HbA1c) Testing Market covered are:
- Ion-Exchange High-Performance Liquid Chromatography (HPLC)
- Direct Enzymatic Assay
- Boronate Affinity Chromatography
- Turbidimetric Inhibition Immunoassay
Major Applications of Hemoglobin A1c (HbA1c) Testing Market covered are:
- Hospitals & Clinics
- Home Care
- Diagnostic Laboratories
Moreover, technological advancements and new product launches have also played a key role in fueling the HbA1c market growth. For instance, in 2019, Abbott launched a rapid point-of-care HbA1c test cleared by the U.S. Food and Drug Administration (U.S. FDA) to aid healthcare professionals in the diagnosis of diabetes and assessment of the risk of developing diabetes. This assay is also cleared by the U.S. FDA for utilization in monitoring long-term glycemic control. Similarly, in 2018, PTS Diagnostics had announced the upgrading of the at-home A1CNow Self Check system by doubling the number of A1C tests per package.
Research objectives:-
– To study and analyze the global Hemoglobin A1c (HbA1c) Testing consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Hemoglobin A1c (HbA1c) Testing market by identifying its various sub-segments.
– Focuses on the key global Hemoglobin A1c (HbA1c) Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Hemoglobin A1c (HbA1c) Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/406
Table of Contents
- INTRODUCTION
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecasted Years – 2020 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
- GLOBAL HEMOGLOBIN A1c (Hb A1c) TESTING MARKET – ANALYSIS & FORECAST, BY PRODUCT TYPE
- Instruments
- Handheld Device
- Benchtop Device
- Consumables
- Instruments
- GLOBAL HEMOGLOBIN A1c (Hb A1c) TESTING MARKET – ANALYSIS & FORECAST, BY TECHNOLOGY
- Ion-Exchange High-Performance Liquid Chromatography (HPLC)
- Direct Enzymatic Assay
- Boronate Affinity Chromatography
- Turbidimetric Inhibition Immunoassay
- Other Technologies
- GLOBAL HEMOGLOBIN A1c (Hb A1c) TESTING MARKET – ANALYSIS & FORECAST, BY END-USER
- Hospitals & Clinics
- Home Care
- Diagnostic Laboratories
- GLOBAL HEMOGLOBIN A1c (Hb A1c) TESTING MARKET – ANALYSIS & FORECAST, BY REGION
- North America Hemoglobin A1c (Hb A1c) Testing Market
- Europe Hemoglobin A1c (Hb A1c) Testing Market
- Asia Pacific Hemoglobin A1c (Hb A1c) Testing Market
- Rest of the World (RoW) Hemoglobin A1c (Hb A1c) Testing Market
- COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, Recent Developments)
- Bio-Rad Laboratories, Inc.
- Abbott
- Siemens Healthcare Private Limited
- F. Hoffmann-La Roche Ltd
- ARKRAY, Inc.
- PTS Diagnostics
- Tosoh Corporation
- Trinity Biotech
- SEBIA
- Nova Biomedical
*Financial details might not be captured for privately-held companies or companies that do not report this information in the public domain.
Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/406
In the end, Hemoglobin A1c (HbA1c) Testing industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.
About Market Industry Reports-
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com